Intracellular cholesterol trafficking by Sviridov, Dmitri
Histol Histopathol (1 999) 14: 305-31 9 
http://www.ehu.es/histol-histopathol 
Histology and 
Histopathology 
Invited Revie W 
Intracellular cholesterol trafficking 
D. Sviridov 
Baker Medical Research Institute, Melbourne, Australia 
Summary. The overall picture of intracellular 
cholesterol trafficking is very complex. The transfer of 
cholesterol within the cell depends on the contribution of 
several trafficking mechanisms. The known elements of 
cholesterol trafficking machinery include clathrin-coated 
pits, scavenger receptor type B1, caveolae, phospholipd 
rafts, Niemann-Pick C disease protein, sterol carrier 
protein 2, multidrug resistance protein, microsomal 
triglyceride transfer protein and steroidogenic acute 
regulation protein. Several pathways of intracellular 
cholesterol trafficking, for example retroendocytosis and 
cholesterol absorption in the intestine, are yet to be 
connected to specific structural elements. The 
contribution of different pathways depends on cell type, 
the source and destination of cholesterol and cellular 
cholesterol content and requirements. Some pathways 
are found in most, if not all, cell types, while others are 
associated with the specialized function of a particular 
cell type, for example, lipoprotein assembly in the liver 
or intestine and steroid hormone synthesis in steroido- 
genic tissue. Certain routes of intracellular cholesterol 
trafficking are heavily backed up by several auxiliary 
pathways, others entirely depend on a single functional 
element. In this review we describe the intracellular 
machinery involved in the intracellular transfer of 
cholesterol and give an overview of both the general and 
specialized pathways of intracellular cholesterol 
trafficking known to date. 
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I. Introduction 
Cholesterol is an essential part of the membranes of 
most animal cells. Apart from maintaining the correct 
structural and physico-chemical properties of the 
membrane (Gibbons et al., 1982; Reinhart, 1990), the 
concentration of cholesterol in the membrane is related 
to a number of regulatory mechanisms (Wang et al., 
1994; Shimano et al., 1996). Although rarely seen, 
deficiency of cholesterol is associated with the inhibition 
of cell growth, while the more common excessive 
accumulation of cholesterol is associated with a number 
of pathological conditions, most notably atherosclerosis, 
an underlying cause of most cardiovascular diseases. 
There are two sources of cell cholesterol: endo- 
genous cholesterol biosynthesis and uptake of 
cholesterol from plasma lipoproteins. Both these sources 
deliver cholesterol in either the free form of cholesterol 
or as cholesteryl esters (CE). Cholesterol biosynthesis 
from acetate or other cholesterol precursors produces 
free cholesterol or if esterified by acetyl:cholesterol 
acyltransferase (ACAT), cholesteryl esters. Exogenous 
lipoproteins carry and deliver to cells both free 
cholesterol and cholesteryl esters. Free cholesterol can 
be converted to cholesteryl esters both intracellularly 
and extracellularly, while hydrolysis of cholesteryl esters 
to free cholesterol only occurs intracellularly. All 
pathways related to cholesterol supply are very tightly 
regulated in response to cellular cholesterol content 
(Dietschy et al., 1993). 
In addition to controlling delivery of cholesterol to 
cells, cells also regulate the amount of cholesterol 
removed (Fielding and Fielding, 1995a, 1997). Hepato- 
cytes are the only cells capable of catabolizing 
cholesterol, converting it to bile acids, a process 
controlled by the enzyme cholesterol 7a-hydroxylase 
(Russell and Setchell, 1992). Hepatocytes, enterocytes 
and, to a lesser extent, macrophages can release 
cholesterol with newly synthesized lipoproteins. 
Adrenals and gonads can convert cholesterol into steroid 














